The most notable companies in this group are Merck & Co (NYSE:MRK), Amgen (NASDAQ:AMGN), ConocoPhillips (NYSE:COP), American Express Company (NYSE:AXP), Occidental Petroleum Corp (NYSE:OXY), DR Horton (NYSE:DHI), Simon Property Group (NYSE:SPG), Lennar Corp (NYSE:LEN).
The investment seeks long-term capital appreciation.
To achieve its investment objective, the fund will maintain approximately 25-30 companies in its portfolio and will invest in the common stocks of large capitalization ("large-cap") U.S. companies. The fund's manager considers large-cap companies to be those publicly traded U.S. companies with capitalizations exceeding $5 billion. It is non-diversified.
The average market capitalization across the Smead Value R1 MF is 114.3B. The market cap for tickers in the group ranges from 12.5B to 253.86B. MRK holds the highest valuation in this group at 253.86B. The lowest valued company is OVV at 12.5B.
The average weekly volume growth across all stocks in the Smead Value R1 MF was 20%. For the same stocks of the MF, the average monthly volume growth was -16% and the average quarterly volume growth was -6%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 58
P/E Growth Rating: 45
Price Growth Rating: 36
SMR Rating: 35
Profit Risk Rating: 41
Seasonality Score: 28 (-100 ... +100)